Overview

Join us for this 1-hour, CME-certified live dinner program to gain expert insights into the evolving treatment landscape for desmoid tumors. In an engaging discussion format, Mrinal M. Gounder, MD and Tony Philip, MD, FACP, FASCO, will explore key aspects of desmoid tumor management—including disease pathogenesis, diagnosis, treatment selection, and adverse event management—through patient case discussions and review of the latest clinical data.

Learning Objectives

1. Describe evidence-based strategies for the diagnosis of desmoid tumors, including molecular profiling, imaging modalities, and the role of multidisciplinary team consultation.
2. Discuss the efficacy, safety, and expected outcomes of standard-of-care therapies with patients under active surveillance considering systemic treatment.
3. Develop individualized treatment plans for patients with progressive, unresectable, recurrent, or refractory desmoid tumors based on available clinical data, clinical guidelines, and patient-specific factors.
4. Recognize, assess, and manage treatment-related adverse events associated with systemic therapies.

Target Audience

This activity is designed to educate oncology physicians as well as advanced practice providers, physician assistants, pharmacists, and nurse specialists involved in the care of patients with desmoid tumors.

This program is supported by an independent educational grant from SpringWorks Therapeutics, Inc.

Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email, mailing address, and payment information). This information is confidential and will only be used to contact you regarding your registration.